← All companies
AWHL
Aspira Women's Health Inc.
$0.35
+0.02 +6.06%
Key statistics
from XBRL data in SEC filingsMarket cap
$15.2M
Revenue (TTM)
$8.90M
Net income (TTM)
$2.52M
EPS (TTM)
$-0.33
P/E ratio
—
Dividend yield
—
Free cash flow
-$7.04M
Cash
$1.34M
Total assets
$5.09M
Gross margin
60.9%
52-week range
$0.18 – $0.71
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Entered a material agreement; Took on a direct financial obligation
Jul 15, 2026
8-K/A
Director or officer change
Jul 7, 2026
8-K
Director or officer change
Jun 22, 2026
8-K
Shareholder vote results
Jun 17, 2026
8-K
Entered a material agreement; Unregistered sale of equity
Jun 9, 2026
8-K
Entered a material agreement
May 26, 2026
10-Q
Quarter ended 2026-03-31
May 15, 2026
8-K
Director or officer change
Apr 30, 2026
10-K
Fiscal year ended 2025-12-31
Apr 1, 2026
8-K/A
Entered a material agreement
Mar 25, 2026
8-K
Entered a material agreement; Took on a direct financial obligation
Jan 30, 2026
8-K
Regulation FD disclosure
Dec 31, 2025
8-K
Entered a material agreement; Unregistered sale of equity
Dec 23, 2025
8-K
Entered a material agreement
Dec 22, 2025
10-Q
Quarter ended 2025-09-30
Nov 14, 2025
8-K
Results of operations (earnings release)
Nov 14, 2025
8-K/A
Entered a material agreement; Unregistered sale of equity
Nov 3, 2025
8-K
Other events
Oct 15, 2025
8-K
Entered a material agreement; Unregistered sale of equity
Sep 25, 2025
8-K
Entered a material agreement; Unregistered sale of equity; Other events
Sep 18, 2025
8-K
Director or officer change
Sep 3, 2025
8-K
Results of operations (earnings release)
Aug 13, 2025
10-Q
Quarter ended 2025-06-30
Aug 13, 2025
8-K
Director or officer change
Jul 15, 2025
8-K
Other events
Jun 11, 2025
8-K
Shareholder vote results
Jun 4, 2025
10-Q
Quarter ended 2025-03-31
May 19, 2025
8-K
Results of operations (earnings release)
May 19, 2025
8-K
Delisting notice or listing-rule failure
Apr 16, 2025
8-K
Entered a material agreement; Unregistered sale of equity; Director or officer change; Other events
Apr 8, 2025
8-K
Amended charter or bylaws
Mar 31, 2025
8-K
Director or officer change
Mar 31, 2025
10-K
Fiscal year ended 2024-12-31
Mar 27, 2025
8-K
Results of operations (earnings release)
Mar 27, 2025
8-K
Director or officer change
Mar 25, 2025
8-K
Director or officer change
Mar 19, 2025
8-K
Entered a material agreement; Unregistered sale of equity; Other events
Mar 11, 2025
8-K
Delisting notice or listing-rule failure
Feb 14, 2025
8-K
Director or officer change
Feb 10, 2025
8-K
Director or officer change
Jan 31, 2025